Just another example of the major problem with pharma funding med schools, paying for continuing medical education, paying professors and other massive undisclosed conflicts of interest. The top med schools are some of the worst offenders.
I wonder if any of this is correlated to negative health outcomes? Nah, maximizing shareholder value and doing what’s best for the patient are totally compatible.
https://www.bostonglobe.com/news/nation/2015/08/05/doctors-l...
https://ethics.harvard.edu/event/drug-companies-and-medicine...